SherpaBonds
US78081BAT08 · Corp · USDInvestment Grade · Baa2

Royalty Pharma Plc 4.45% 2031/03

Royalty Pharma PlcUnited StatesGLOBALSenior Unsecured
SHARE
▶ Start radio
MID PRICE
98.86
par = 100
YIELD TO MAT.
4.71%
semi-annual
COUPON
4.450%
semi-annual · fixed
MATURITY
2031-03-25
bullet · 4.87y
OUTSTANDING
—
not disclosed
AS OF
2026-05-07

Sign up free to see prices on this bond

Free accounts get 40 bond price views per month — 4× the anonymous quota. Pro is unlimited.

Sign inSign up free

About this bond

AI BRIEF · GROUNDED IN STRUCTURED DATA
About the issuer

Royalty Pharma is a private equity investor firm founded in 1996. It purchases the rights to royalties on future drug sales. It claims to own partial rights to 7 of the top 30 selling drugs in the United States.

Source: Wikipedia →

Risk analytics

SEMI-ANNUAL · BULLET · PAR 100
Modified duration
4.31 y
1bp ↑ ≈ -0.043% P&L
Convexity
21.87
higher = more curvature
Years to maturity
4.87 y
YTM source
Ingested
Market signals · funds disclosing this bond
SignalCategoryExposureLast moveWeightAs of
Vanguard Total Bond Market
Vanguard
US Aggregate$13.7M—0.00%2026-03-31
iShares iBonds Dec 2031 Term Corporate
iShares
iBonds 2031 Corporate$3.3M▼ $9K0.14%2026-05-07
Invesco BulletShares 2031 Corporate Bond
Invesco
BulletShares 2031 Corporate$2.8M▲ $2K0.17%2026-05-05
iShares 1-5 Year Investment Grade Corporate Bond
iShares
US IG Corporate 1-5Y$2.2M▼ $4K0.01%2026-05-07
iShares Core U.S. Aggregate Bond
iShares
US Aggregate$1.9M▼ $5K0.00%2026-05-07
SPDR Portfolio Intermediate Term Corporate Bond
SPDR
US IG Corporate Intermediate$1.7M▲ $2K0.02%2026-05-05
iShares Broad USD Investment Grade Corporate Bond
iShares
US Broad IG Corporate$1.3M▼ $2K0.01%2026-05-07
SPDR DoubleLine Short Duration Total Return Tactical
SPDR
US Active Short Duration$1.1M▲ $7990.24%2026-05-05
iShares 0-5 Year Investment Grade Corporate Bond
iShares
US IG Corporate$472K▼ $1K0.02%2026-05-07
iShares Systematic Bond
iShares
US Multi-Sector$396K▼ $6720.04%2026-05-07
iShares Core Universal USD Bond
iShares
US Aggregate$372K▼ $1K0.00%2026-05-07
SPDR Portfolio Aggregate Bond
SPDR
US Aggregate$345K▲ $3330.00%2026-05-05
iShares Intermediate Government/Credit Bond
iShares
US Govt/Credit$84K▼ $2440.00%2026-05-07
iShares ESG Aware U.S. Aggregate Bond
iShares
US ESG Aggregate$25K▼ $720.00%2026-05-07
iShares Interest Rate Hedged U.S. Aggregate Bond
iShares
US Aggregate$68—0.00%2026-05-07
Subscribe to reveal which signals are holding this bond.Subscribe →

Price history

Sherpa Signal

AS OF 2026-05-07

Institutional footprint · signal-level holdings

41/ 100Active coverage
Interpretation. Light institutional footprint, with net distribution
HOLDERS
15
▲ 1 signal in 7d
AGGREGATE EXPOSURE
$29.6M
USD across all
TOP CONCENTRATION
46.4%
largest holder
FLOW
▼ $4.5M
▲ 1 signal in 7d

Sherpa Signal is derived from a panel of tracked institutional portfolios. Names of individual holders are not disclosed.

100K PAR NOTIONAL · MARKET VALUE
98,860 USD
PRICE
98.86

RFQ routing · coming soon

Security details

VIA OPENFIGI
Canonical
RPRX 4.45 03/25/31
FIGI
BBG01X0X8FM7
CUSIP
78081BAT0
ISIN
US78081BAT08
Type
Corp
Issued
2025-09-16
Face value
100 USD
Ticker
RPRX 4.45 03/25/31
Sec. type
GLOBAL
Seniority
Senior Unsecured

Issuer curve

RPRX · 10 PTS

Yield (%) plotted against years-to-maturity. This bond highlighted in amber.

Bonds like this

HEURISTIC

Same currency & sector, maturity within 7 years. Ranked by overlapping institutional owners, issuer match, and rating distance.

Royalty Pharma Plc 2.15% 09/2031
Royalty Pharma Plc
2031-09
4.78%
+7 bps yield+5mo duration6 signals in commonSame issuer
Royalty Pharma Plc 2.2% 09/2030
Royalty Pharma Plc
2030-09
4.68%
−3 bps yield−7mo duration8 signals in commonSame issuer
Royalty Pharma Plc 5.15% 09/2029
Royalty Pharma Plc
2029-09
4.60%
−11 bps yield−2y duration7 signals in commonSame issuer
Royalty Pharma Plc 5.4% 09/2034
Royalty Pharma Plc
2034-09
5.19%
+48 bps yield+3y duration6 signals in commonSame issuer
Royalty Pharma Plc 1.75% 09/2027
Royalty Pharma Plc
2027-09
4.44%
−27 bps yield−4y duration7 signals in commonSame issuer
Royalty Pharma Plc 5.2% 09/2035
Royalty Pharma Plc
2035-09
5.28%
+57 bps yield+5y duration6 signals in commonSame issuer